Chloramphenicol
Chloramphenicol antibiotic medicaments, measured-dose formulations
HSN 3004 20 50 (Chloramphenicol) is governed by the Ministry of Health and Family Welfare (MOHFW), which prohibits import of chloramphenicol and its formulations for use in any food-producing animal rearing system under S.O. 1158(E) dated 12-03-2025. Non-prohibited imports require a valid drug registration certificate and import licence under the Drugs and Cosmetics Act, 1940, with the Directorate General of Foreign Trade (DGFT) administering the ITC (HS) policy overlay.
- Import licence for drugs from CDSCO
- Registration certificate from CDSCO
- Batch release certificate from exporter
Procedural directions for customs clearance are issued by: Directorate General of Foreign Trade.
- 1Verify that the consignment does not constitute chloramphenicol or its formulations intended for use in any food-producing animal rearing system, which are categorically prohibited under S.O. 1158(E) dated 12-03-2025 issued by MOHFW. A consignment of prohibited formulations is liable to outright rejection and confiscation at the bill of entry.S.O. 1158(E) dated 12-03-2025 · Ministry of Health and Family Welfare
- 2Upload all mandatory documents in e-Sanchit before filing the bill of entry: Certificate of Analysis — Drug (document code 0010dc), Batch Release Certificate (document code 0030dc), Label of Consignment (document code 0110dc), Registration Certificate for Drugs (document code 101dc1), and Import Licence for Drugs (document code 9111dc). Out-of-charge will not be granted until these five documents are verified in e-Sanchit.CBIC e-Sanchit mandatory document requirement · document codes 0010dc, 0030dc, 0110dc, 101dc1, 9111dc
The most frequent error on this tariff line is importing chloramphenicol formulations without confirming the end-use declaration: the S.O. 1158(E) prohibition is use-specific, not product-specific, meaning a consignment destined for veterinary or aquaculture application in a food-producing animal system is prohibited even if the drug registration certificate is otherwise valid. A missing or ambiguous end-use declaration at the bill of entry is sufficient grounds for detention pending MOHFW clarification, and the importer bears the burden of establishing non-prohibited end use before out-of-charge is granted.